Policy Analysis: Investment, IP
Published:

ETH Zurich: Researchers develop alternative to animal testing for Botox production

A new animal- and cell-free method has been developed to measure the toxic activity of Botulinum neurotoxin (BoNT), e.g. Botox. The invention will avoid the use of mouse LD50 tests for toxicity testing, e.g. in BoNT-containing pharmaceutical products such as Botox.

The method uses functionalized liposomes to determine the toxin’s activity under physiological conditions. A press release about the technology has been published here (article in German).

ETH Zurich is looking for a licensing or collaboration...



Related subjects: Patent

The 2015 Science|Business Annual Summit
The Science|Business Annual Summit brings together leaders from research, industry and policy to debate current and future trends needed to unleash Europe’s technological potential.
Barcelona - 20 November 2015
The future of manufacturing: Industry 4.0 (Date to be confirmed)
A Science|Business public conference
Brussels - 01 October 2015
The Bioeconomy Challenge: Producing more from less
A Science|Business high-level roundtable
Brussels - 29 September 2015
BIG SCIENCE: What’s It Worth?
The world spends millions a year on telescopes, synchrotrons, colliders, DNA databases and other ‘big science’ projects. What does it get for that money?